Joint (JYNT) to Release Earnings on Thursday

Joint (NASDAQ:JYNT) is expected to announce its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect the company to announce earnings of ($0.01) per share and revenue of $13.36 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Thursday, November 6, 2025 at 5:00 PM ET.

Joint (NASDAQ:JYNT) last issued its quarterly earnings data on Thursday, August 7th. The company reported ($0.06) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. Joint had a positive return on equity of 0.60% and a negative net margin of 7.02%.The company had revenue of $13.27 million during the quarter, compared to analysts’ expectations of $13.32 million. On average, analysts expect Joint to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Joint Trading Down 1.9%

Shares of NASDAQ JYNT opened at $8.14 on Thursday. Joint has a twelve month low of $8.01 and a twelve month high of $13.47. The stock has a 50 day moving average of $9.58 and a two-hundred day moving average of $10.43. The stock has a market cap of $124.87 million, a P/E ratio of -24.67 and a beta of 1.45.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. B. Riley cut their price objective on Joint from $20.00 to $18.00 and set a “buy” rating for the company in a research report on Friday, August 8th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Joint in a research report on Wednesday, October 8th. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $16.33.

Insiders Place Their Bets

In other Joint news, Director Christopher M. Grandpre bought 14,388 shares of Joint stock in a transaction that occurred on Friday, August 15th. The shares were purchased at an average cost of $10.88 per share, for a total transaction of $156,541.44. Following the completion of the transaction, the director owned 19,383 shares of the company’s stock, valued at $210,887.04. This represents a 288.05% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders bought 34,388 shares of company stock worth $367,641 in the last quarter. Corporate insiders own 27.90% of the company’s stock.

Hedge Funds Weigh In On Joint

Large investors have recently modified their holdings of the company. JPMorgan Chase & Co. raised its holdings in shares of Joint by 32.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 7,412 shares of the company’s stock worth $86,000 after purchasing an additional 1,810 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Joint by 25.9% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,244 shares of the company’s stock worth $95,000 after purchasing an additional 1,698 shares during the period. Rhumbline Advisers raised its holdings in shares of Joint by 25.9% in the 2nd quarter. Rhumbline Advisers now owns 20,934 shares of the company’s stock worth $242,000 after purchasing an additional 4,307 shares during the period. American Century Companies Inc. raised its holdings in shares of Joint by 13.9% in the 2nd quarter. American Century Companies Inc. now owns 27,572 shares of the company’s stock worth $318,000 after purchasing an additional 3,366 shares during the period. Finally, Geode Capital Management LLC raised its holdings in shares of Joint by 17.6% in the 2nd quarter. Geode Capital Management LLC now owns 345,330 shares of the company’s stock worth $3,986,000 after purchasing an additional 51,704 shares during the period. 76.88% of the stock is currently owned by hedge funds and other institutional investors.

Joint Company Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.